Industry

Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment

GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluating GLY-200 in Patients with Type 2 Diabetes Anticipated in Early 2023 BOSTON–(BUSINESS … [Read more…]

Trio Health and Allergy Partners to Form National Allergy and Asthma Patient Registry

LOUISVILLE, Colo. & ASHEVILLE, N.C.–(BUSINESS WIRE)–Trio Health (Trio), a leading provider of real-time data on real-world patients, and Allergy Partners, the nation’s largest single speciality practice, today announced a strategic partnership in which Allergy Partners will anchor the formation of a national allergy and asthma patient registry, leading the path forward in real world evidence … [Read more…]

Atavistik Bio Announces Formation of Scientific Advisory Board

Scientific Advisory Board Strengthens Atavistik Bio’s Mission of Harnessing the Power of Protein-Metabolite Interactions to add a New Lens to Drug Discovery CAMBRIDGE, Mass.–(BUSINESS WIRE)–Atavistik Bio, a pre-clinical biotechnology company that is leveraging their scalable and systematic platform to identify novel regulatory sites on proteins to restore function in disease, announced the formation of its … [Read more…]

Maxwell Biosciences Expands Leadership Team with the Appointment of Three Senior Executives

Industry-leading talent joins leadership team as company accelerates its CLAROMER™ drug platform Tony Verco, MD, MBA, appointed Chief Medical Officer Beth Burnside, PhD, appointed Senior Vice President of Research and Development Strategy Donald Treacy, Jr., PhD, appointed Senior Vice President, Development Operations AUSTIN, Texas–(BUSINESS WIRE)–Maxwell Biosciences (“Maxwell”), a preclinical drug platform company focused on the … [Read more…]

The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

SOUTH SAN FRANCISCO, Calif. & SYDNEY–(BUSINESS WIRE)–Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development. Australia’s commitment to the growing market of synthetic … [Read more…]

National Hemophilia Foundation Launches “Pathway to Cures,” a Venture Philanthropy Fund to Accelerate the Development of Transformational Therapies and Technologies for Inheritable Blood Disorders

Fund starting with $3.5 million of commitments; targeting $20 million Venture Philanthropy model to transform the therapeutic development landscape for disease category impacting more than 20 million people NEW YORK–(BUSINESS WIRE)–National Hemophilia Foundation (NHF), the leading global organization funding inheritable blood disorders research, education, and community advocacy, today announced the launch of Pathway to Cures … [Read more…]

Battery Ventures Forms ifp-labs to Expand Advanced Laboratory Testing and Diagnostic Services Across Europe

Building off initial investment, global investment firm adds Microsearch Laboratories to increase testing capacity; ifp-labs also announces new executive team to bring group forward BERLIN–(BUSINESS WIRE)–#industrialtech–ifp-labs, a laboratory group providing analytical testing services for food, feed, water and pharmaceuticals created by global, technology-focused investment firm Battery Ventures, today announced its launch. With its headquarters in … [Read more…]

See a more complete picture of your health with Index BPM, an FDA-cleared smart blood pressure monitor from Garmin

Clinically validated and easy to use, Index BPM is an all-in-one solution to view blood pressure readings alongside other Garmin health and fitness data in the Garmin Connect app OLATHE, Kan.–(BUSINESS WIRE)–Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Index™ BPM, its first smart blood pressure monitor that lets users … [Read more…]

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

− NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron® accelerator technology – BELOIT, Wis. & LOUVAIN-LA-NEUVE, Belgium–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and IBA (Ion Beam Applications S.A., EURONEXT), the world … [Read more…]

Alnylam Receives Approval in Europe for AMVUTTRA® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy

– AMVUTTRA Demonstrated Halting or Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – Decision Follows Positive Opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in July 2022 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that … [Read more…]